Literature DB >> 8121692

The misuse of analysis of variance to detect synergy in combination drug studies.

Robert M Caudle1, Gene M Williams.   

Abstract

Drug combination studies often examine the possibility of synergy between drugs. Synergy is defined as an effect of a combination of drugs greater than that expected from the effects of the drugs given individually. One technique used by several investigators is the use of analysis of variance (ANOVA) to determine synergy. In this discussion, the argument is made that due to the pharmacology of drug combination studies the conditions necessary to support the use of ANOVA to detect synergy are typically not met. Therefore, the ANOVA technique is invalid for these drug combination studies.

Mesh:

Substances:

Year:  1993        PMID: 8121692     DOI: 10.1016/0304-3959(93)90006-B

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

Review 1.  Evaluation of synergism in drug combinations and reference models for future orientations in oncology.

Authors:  Diana Duarte; Nuno Vale
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-05-12

2.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

3.  Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam.

Authors:  Lily Q Cao; Michael C Montana; Allison L Germann; Daniel J Shin; Sampurna Chakrabarti; Steven Mennerick; Carla M Yuede; David F Wozniak; Alex S Evers; Gustav Akk
Journal:  Sci Rep       Date:  2018-07-09       Impact factor: 4.379

Review 4.  Assessing the Effect of Mycotoxin Combinations: Which Mathematical Model Is (the Most) Appropriate?

Authors:  Domagoj Kifer; Daniela Jakšić; Maja Šegvić Klarić
Journal:  Toxins (Basel)       Date:  2020-02-29       Impact factor: 4.546

5.  Statistical determination of synergy based on Bliss definition of drugs independence.

Authors:  Eugene Demidenko; Todd W Miller
Journal:  PLoS One       Date:  2019-11-25       Impact factor: 3.240

Review 6.  Analysis of drug combinations: current methodological landscape.

Authors:  Julie Foucquier; Mickael Guedj
Journal:  Pharmacol Res Perspect       Date:  2015-05-20

7.  Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice.

Authors:  Kathrin Gnoth; Stefanie Geissler; Julia Feldhaus; Nadine Taudte; Victoria Ilse; Sebastian Zürner; Sebastian Greiser; Ulf-Dietrich Braumann; Jens-Ulrich Rahfeld; Holger Cynis; Stephan Schilling
Journal:  Biomolecules       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.